Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18979375 | Coffee Bean Compositions Comprising Paraxanthine and Methods for Their Production | December 2024 | February 2025 | Allow | 2 | 0 | 0 | No | No |
| 18737162 | ODOR CONTROL COMPOSITION CONCENTRATES | June 2024 | March 2025 | Allow | 9 | 1 | 1 | Yes | No |
| 18436814 | Method for Synthesizing Selenium Nanoparticles from Edible Mushrooms | February 2024 | April 2025 | Abandon | 14 | 2 | 0 | No | No |
| 18436404 | Method for Synthesizing Selenium Nanoparticles from Edible Mushrooms | February 2024 | March 2025 | Abandon | 13 | 2 | 0 | No | No |
| 18412318 | COMPOSITIONS AND METHODS FOR THEIR PRODUCTION | January 2024 | September 2024 | Allow | 8 | 1 | 0 | No | No |
| 18508748 | IMAC-ENRICHED MICROALGAL CULTURE SUPERNATANT AND USES THEREOF | November 2023 | December 2024 | Allow | 13 | 1 | 0 | No | No |
| 18502684 | 2-BENZO-[3,4-B]QUINOLINO-[B,G]INDENO[1',2':3,4]FLUORENO-[1,2-D]OXONINE-24-CHLORO-5,11,16,21-TETRAONE AS AN ANTIMICROBIAL COMPOUND | November 2023 | January 2024 | Allow | 2 | 0 | 0 | No | No |
| 18371084 | Method for Synthesizing Selenium Nanoparticles from Edible Mushrooms | September 2023 | May 2025 | Abandon | 20 | 3 | 1 | No | No |
| 18454753 | Method for Manufacturing a Calcified Tissue Substitute | August 2023 | March 2025 | Allow | 19 | 1 | 0 | No | No |
| 18234938 | Skin Care Composition and Method of Using the Same | August 2023 | December 2024 | Abandon | 16 | 1 | 0 | No | No |
| 18303694 | BROMIDE SOURCE FOR USE IN TREATING AUTISM SPECTRAL DISORDER | April 2023 | March 2024 | Allow | 10 | 1 | 0 | No | No |
| 18136350 | APPLICATION OF A HYDROGEL IN THE PREPARATION OF PRODUCTS FOR THE TREATMENT OF BACTERIAL INFECTIONS | April 2023 | February 2024 | Allow | 10 | 1 | 0 | No | No |
| 18249274 | FORMULATION AND NONCOVALENT STABILIZATION OF OLIVETOLIC ACID DERIVATIVES | April 2023 | April 2025 | Allow | 24 | 2 | 1 | Yes | No |
| 18299323 | COMPOSITIONS AND METHODS FOR THEIR PRODUCTION | April 2023 | November 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 18175573 | STABILIZED ACTIVE OXYGEN-GENERATING ANTISEPTIC COMPOSITIONS, IRRIGATION SOLUTIONS, AND ARTICLES | February 2023 | January 2024 | Abandon | 10 | 1 | 0 | No | No |
| 17979490 | NOVEL IRON COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | November 2022 | February 2023 | Allow | 3 | 0 | 0 | No | No |
| 17966361 | Hair Cosmetic Composition Comprising Silicones And Surfactants, And Cosmetic Treatment Process | October 2022 | December 2023 | Allow | 14 | 1 | 0 | No | No |
| 17937327 | CBD FORMULATIONS AND USES THEREOF | September 2022 | December 2024 | Abandon | 26 | 1 | 0 | No | No |
| 17878324 | HONEY/SURFACTANT COMBINATIONS FOR WOUND TREATMENT | August 2022 | January 2024 | Abandon | 18 | 1 | 0 | No | No |
| 17836617 | COMPOSITIONS AND METHODS FOR NASAL ADMINISTRATION OF DRUGS TO BRAIN AND FOR SYSTEMIC EFFECT | June 2022 | April 2024 | Allow | 22 | 1 | 0 | No | No |
| 17836751 | PHYTOTHERAPY COMPOSITION ASSOCIATED WITH POLYVITAMIN AND MINERAL SUPPLEMENTS | June 2022 | December 2023 | Abandon | 19 | 1 | 0 | No | No |
| 17739103 | CBD FORMULATIONS AND USES THEREOF | May 2022 | December 2024 | Abandon | 31 | 1 | 0 | No | No |
| 17726843 | USE OF LACTIC ACID BACTERIA OR FERMENTATION PRODUCT THEREOF FOR MAINTAINING OR IMPROVING GASTROINTESTINAL CONDITION | April 2022 | April 2024 | Allow | 24 | 2 | 0 | No | No |
| 17716694 | STABLE EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF CLOZAPINE | April 2022 | November 2023 | Allow | 19 | 4 | 0 | Yes | No |
| 17651363 | STABILIZED ACTIVE OXYGEN-GENERATING ANTISEPTIC COMPOSITIONS, IRRIGATION SOLUTIONS, AND ARTICLES | February 2022 | February 2023 | Allow | 12 | 3 | 1 | Yes | No |
| 17672072 | NOVEL IRON COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | February 2022 | July 2023 | Allow | 17 | 1 | 0 | No | No |
| 17589034 | PERFORMANCE ENHANCING BEVERAGE | January 2022 | January 2024 | Abandon | 23 | 1 | 0 | No | No |
| 17584502 | ANTIMICROBIAL AND CLEANSING COMPOSITION | January 2022 | February 2024 | Abandon | 25 | 1 | 1 | No | No |
| 17575276 | METHOD OF PREVENTING COVID-19 INFECTION | January 2022 | December 2024 | Abandon | 35 | 6 | 0 | Yes | No |
| 17572034 | MATERIALS AND METHODS FOR ENHANCING BONE CELL DIFFERENTIATION | January 2022 | December 2023 | Abandon | 23 | 0 | 1 | No | No |
| 17572286 | COMPOSITIONS AND METHODS OF TREATMENT OF CHRONIC INFECTIOUS DISEASES | January 2022 | December 2023 | Abandon | 23 | 0 | 1 | No | No |
| 17567759 | DRUG DELIVERY COMPOSITION AND A METHOD OF ADMINISTERING THE DRUG | January 2022 | December 2022 | Abandon | 11 | 1 | 0 | No | No |
| 17547624 | THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES | December 2021 | June 2023 | Allow | 18 | 2 | 1 | Yes | No |
| 17484916 | MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS | September 2021 | August 2022 | Abandon | 11 | 2 | 0 | No | No |
| 17373781 | ANHYDROUS ANTIMICROBIAL TOPICAL FORMULATIONS AND METHODS OF USE THEREOF | July 2021 | June 2024 | Allow | 35 | 2 | 0 | Yes | No |
| 17367577 | COSMETIC COMPOSITION INCLUDING MICROSPHERES CONTAINING HIGH CONCENTRATION OF OXYGEN AND METHOD OF PREPARING THE SAME | July 2021 | December 2023 | Abandon | 30 | 2 | 0 | No | No |
| 17335193 | ANTIOXIDANT, SKIN-WHITENING AND WRINKLE-REDUCING MULTIFUNCTIONAL COSMETIC COMPOSITION CONTAINING FERMENTED RICE BY-PRODUCT EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT | June 2021 | March 2025 | Abandon | 46 | 4 | 0 | No | No |
| 17298659 | COMPOSITIONS FOR WEIGHT MANAGEMENT | May 2021 | January 2025 | Allow | 43 | 2 | 1 | No | No |
| 17327308 | STABLE PARENTERAL COMPOSITION OF LACOSAMIDE | May 2021 | February 2022 | Allow | 8 | 2 | 1 | No | No |
| 17322299 | MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS | May 2021 | March 2023 | Abandon | 22 | 3 | 0 | Yes | Yes |
| 17294586 | USE OF POLYETHYLENE GLYCOL FOR THE CONTROL OF PLANT-DAMAGING INSECTS AND ACARI | May 2021 | September 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17290919 | WATER-SOLUBLE EFFERVESCENT SOLID PERFUME | May 2021 | December 2024 | Abandon | 43 | 2 | 0 | No | No |
| 17288873 | ACTIVE SUBSTANCE COMPOSITION FOR MODIFYING HAIR SURFACE AND CHANGING THE SHAPE OF HAIR | April 2021 | March 2025 | Abandon | 47 | 2 | 1 | No | No |
| 17282832 | A METHOD FOR FIGHTING FEMALE BODY ODORS | April 2021 | May 2024 | Abandon | 38 | 2 | 0 | No | No |
| 17218773 | METHODS AND COMPOSITIONS FOR IMPROVING SKIN | March 2021 | March 2024 | Allow | 35 | 3 | 1 | Yes | No |
| 17217020 | SILICONE OIL FREE ANTIPERSPIRANTS | March 2021 | March 2024 | Abandon | 35 | 2 | 0 | No | No |
| 17274073 | POLYMER CONJUGATE BONDED TO TERTIARY AMINE COMPOUND OR IMINE COMPOUND AND PRODUCTION METHOD THEREFOR | March 2021 | September 2024 | Abandon | 43 | 0 | 1 | No | No |
| 17273141 | Flat Product for Microbiological Sanitation of the Urogenital Tract | March 2021 | April 2024 | Abandon | 38 | 2 | 1 | No | No |
| 17270539 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MASTITIS | February 2021 | April 2025 | Abandon | 50 | 4 | 1 | Yes | No |
| 17174054 | DEUTERATED POLYUNSATURATED FATTY ACIDS OR ESTERS THEREOF FOR COSMETIC APPLICATIONS | February 2021 | May 2025 | Abandon | 51 | 3 | 1 | No | Yes |
| 17168098 | FLECAINIDE COMBINATION AND CONTROLLED-RELEASE FORMULATIONS FOR TREATING HEART DISEASES | February 2021 | March 2022 | Abandon | 13 | 2 | 0 | No | No |
| 17262563 | TOPICAL EMULSION OF AN ANTICHOLINERGIC COMPOUND | January 2021 | July 2024 | Abandon | 42 | 3 | 0 | No | No |
| 17155327 | Skin Care Composition and Method of Using the Same | January 2021 | July 2023 | Allow | 29 | 1 | 1 | Yes | No |
| 17257769 | MIXTURES OF BRANCHED CHAIN KETO ACIDS (BCKA) AND METHOD FOR THE PRODUCTION OF SUCH MIXTURES | January 2021 | January 2023 | Allow | 24 | 1 | 0 | No | No |
| 17132948 | ANTIPERSPIRANT COSMETIC PRODUCT WITHOUT CYCLIC SILICONE OILS | December 2020 | January 2023 | Abandon | 25 | 2 | 0 | No | No |
| 17255532 | STABLE LYOPHILIZED DOSAGE FORM OF PROTEIN | December 2020 | June 2024 | Abandon | 42 | 1 | 0 | No | No |
| 17058224 | Anti-Adhesive Shear Thinning Hydrogels | November 2020 | June 2023 | Abandon | 31 | 1 | 1 | No | No |
| 17057814 | COMPOUNDS FOR PREVENTING AND TREATING SKIN OR MUCOSAL AFFECTIONS HAVING AN INFLAMMATORY COMPONENT | November 2020 | May 2023 | Allow | 30 | 2 | 1 | No | No |
| 17053471 | IMAC-ENRICHED MICROALGAL CULTURE SUPERNATANT AND USES THEREOF | November 2020 | August 2023 | Allow | 33 | 2 | 1 | No | No |
| 17072005 | Interactional Biosystem | October 2020 | June 2023 | Abandon | 32 | 1 | 1 | No | No |
| 17047264 | USE OF SPECIFIC BENZYLIDENE MALONATES FOR PROTECTING THE SKIN FROM CHEMICALLY INDUCED STRESS | October 2020 | February 2023 | Abandon | 28 | 2 | 0 | No | No |
| 15733704 | Siloxanes for treating textiles and for use in cleaning and care formulations | September 2020 | March 2025 | Allow | 53 | 2 | 1 | Yes | No |
| 16982529 | A COMPOSITION FOR USE IN THE TREATMENT OF CONDITIONS CAUSED BY CALCIUM DEFICIENCY | September 2020 | October 2022 | Allow | 25 | 1 | 1 | Yes | No |
| 16981578 | NANODIAMONDS AS ARTIFICIAL PROTEINS FOR REGULATION OF A CELL SIGNALLING SYSTEM | September 2020 | May 2023 | Allow | 32 | 3 | 0 | No | No |
| 16977231 | TOPICAL COMPOSITION | September 2020 | February 2024 | Allow | 42 | 4 | 1 | No | No |
| 16975807 | METHYLPHENIDATE-CONTAINING PATCH | August 2020 | April 2023 | Abandon | 32 | 2 | 1 | No | No |
| 16987941 | CBD FORMULATIONS AND USES THEREOF | August 2020 | October 2022 | Abandon | 26 | 1 | 1 | No | No |
| 16987103 | CONSUMABLE COMPOSITIONS AND METHODS OF PRODUCING THE SAME | August 2020 | March 2023 | Allow | 31 | 4 | 0 | Yes | No |
| 16934526 | METHOD OF REMOTELY CONTROLLING PAIN | July 2020 | July 2025 | Allow | 59 | 8 | 0 | No | No |
| 16919856 | METHOD TO PREPARE PHARMACEUTICAL COMPOSITIONS OF SUGAMMADEX | July 2020 | January 2022 | Allow | 18 | 2 | 0 | Yes | No |
| 16915734 | ANTI-AGING COMPOSITIONS AND SKIN MASKS CONTAINING ANTI-AGING COMPOSITIONS | June 2020 | September 2023 | Allow | 39 | 6 | 0 | No | Yes |
| 16914460 | COSMETIC COMPOSITION INCLUDING MICROSPHERES CONTAINING HIGH CONCENTRATION OF OXYGEN AND METHOD OF PREPARING THE SAME | June 2020 | October 2021 | Abandon | 16 | 2 | 0 | No | No |
| 16913046 | COMPOSITIONS AND METHODS TO TREAT DISEASE | June 2020 | March 2022 | Allow | 20 | 2 | 1 | Yes | No |
| 16912876 | DISSOLVABLE SOLID FIBROUS ARTICLES CONTAINING ANIONIC SURFACTANTS | June 2020 | April 2023 | Allow | 34 | 5 | 0 | Yes | No |
| 16909591 | EYE DROP FORMULATION AND METHOD FOR SUSTAINED DELIVERY OF MEDICAMENT TO THE RETINA | June 2020 | August 2022 | Allow | 25 | 3 | 1 | Yes | No |
| 16904364 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | June 2020 | July 2021 | Allow | 13 | 1 | 1 | Yes | No |
| 16901233 | SURFACTANT-FREE COSMETIC COMPOSITION | June 2020 | September 2021 | Allow | 15 | 3 | 0 | Yes | No |
| 16772776 | FRIGOSTABLE COMPOSITION FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF A TRIPTAN COMPOUND | June 2020 | May 2022 | Allow | 23 | 3 | 0 | Yes | No |
| 16897927 | TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR | June 2020 | November 2021 | Abandon | 17 | 1 | 0 | No | No |
| 16770730 | PROPANEDIOL MONOACETATE MONONITRATE | June 2020 | December 2021 | Allow | 18 | 0 | 0 | Yes | No |
| 16770374 | LIPID EMULSIFIED DRUG DELIVERY SYSTEMS FOR CHEMOPREVENTION AND TREATMENT | June 2020 | November 2022 | Allow | 29 | 2 | 1 | Yes | Yes |
| 16770011 | COMPOSITION BASED ON PROBIOTICS AND USES THEREOF | June 2020 | August 2022 | Allow | 27 | 1 | 1 | No | No |
| 16891178 | RECOVERY DIETARY SUPPLEMENT | June 2020 | January 2023 | Allow | 32 | 3 | 1 | Yes | No |
| 16887243 | SOLID COSMETIC HAIR CONDITIONING AGENTS (FOAMS) | May 2020 | May 2021 | Allow | 11 | 1 | 1 | Yes | No |
| 16760941 | COATED AGROCHEMICAL COMPOSITION | May 2020 | November 2023 | Allow | 42 | 2 | 1 | No | No |
| 16864734 | CLEANSING AND CONDITIONING TABLETS, COMPOSITIONS, AND METHODS OF MANUFACTURE THEREOF | May 2020 | August 2021 | Abandon | 15 | 1 | 1 | No | No |
| 16865263 | ZINC PICOLINATE, MAGNESIUM PICOLINATE AND SELENIUM METHIONINE COMPOSITIONS AND METHODS OF USE | May 2020 | February 2022 | Abandon | 22 | 2 | 0 | No | No |
| 16852133 | CANNABINOID LOZENGE FORMULATION | April 2020 | October 2021 | Allow | 18 | 3 | 0 | Yes | No |
| 16755692 | COSMETIC COMPOSITION CONTAINING NICOTINAMIDE MONONUCLEOTIDE | April 2020 | June 2022 | Abandon | 26 | 2 | 0 | No | No |
| 16846383 | METHOD FOR FORMING A NATURAL HAIR CONDITIONING COMPOSITION | April 2020 | April 2021 | Abandon | 12 | 1 | 0 | No | No |
| 16833593 | Composition of Athletic and Fitness Supplements, Method for Production and Method for Pulmonary Administration of Same | March 2020 | June 2021 | Abandon | 15 | 1 | 1 | No | No |
| 16647135 | SKIN WHITENING COMPOSITION COMPRISING CULTURED PRODUCT OF BACILLUS HWAJINPOENSIS OR EXTRACT THEREOF | March 2020 | March 2022 | Allow | 24 | 2 | 0 | No | No |
| 16645860 | ANTIOXIDANT, SKIN-WHITENING AND WRINKLE-REDUCING MULTIFUNCTIONAL COSMETIC COMPOSITION CONTAINING FERMENTED RICE BY-PRODUCT EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT | March 2020 | September 2021 | Abandon | 18 | 1 | 0 | No | No |
| 16645878 | COMPOSITIONS COMPRISING LESPEDEZA PLANT EXTRACT | March 2020 | August 2024 | Abandon | 53 | 6 | 0 | No | No |
| 16814163 | COMPOSITIONS AND METHODS FOR NASAL ADMINISTRATION OF DRUGS TO BRAIN AND FOR SYSTEMIC EFFECT | March 2020 | March 2022 | Allow | 24 | 2 | 1 | Yes | No |
| 16644101 | COSMETIC COMPOSITION COMPRISING DENDROBIUM CANDIDUM FLOWER EXTRACT | March 2020 | November 2022 | Abandon | 32 | 2 | 0 | Yes | Yes |
| 16805223 | NOVEL IRON COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | February 2020 | November 2021 | Allow | 20 | 3 | 0 | Yes | No |
| 16642999 | WATER BASED CONCENTRATED PRODUCT FORMS OF OIL-SOLUBLE ORGANIC UV ABSORBERS | February 2020 | October 2023 | Allow | 44 | 3 | 1 | Yes | No |
| 16642557 | COMPOSITIONS AND METHODS FOR INCREASING BUTYRATE PRODUCTION | February 2020 | November 2023 | Allow | 44 | 4 | 1 | Yes | No |
| 16641709 | A PERSONAL CARE COMPOSITION | February 2020 | June 2022 | Allow | 27 | 2 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ASAN, ALPARSLAN NMN.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 25.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner ASAN, ALPARSLAN NMN works in Art Unit 1613 and has examined 132 patent applications in our dataset. With an allowance rate of 50.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 29 months.
Examiner ASAN, ALPARSLAN NMN's allowance rate of 50.8% places them in the 8% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by ASAN, ALPARSLAN NMN receive 2.21 office actions before reaching final disposition. This places the examiner in the 75% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by ASAN, ALPARSLAN NMN is 29 months. This places the examiner in the 44% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +51.1% benefit to allowance rate for applications examined by ASAN, ALPARSLAN NMN. This interview benefit is in the 94% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 23.7% of applications are subsequently allowed. This success rate is in the 24% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 29.5% of cases where such amendments are filed. This entry rate is in the 34% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 0% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 84% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 25.0% are granted (fully or in part). This grant rate is in the 15% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.